Unlike other tumor suppressors and negative regulators of the cell cycle, the p27 gene CDKN1B, is rarely mutated in human cancers but instead p27 levels are highly regulated by post-translational modifications [7]. This evidence concerns the gene CDKN1B and neoplasm.